"China's lymphoma patients throughout the management of quality control standards" issued in Beijing, to solve the needs of patients

To implement the State Council's Action Plan for Further Improvement of Medical Services, promote the "Healthy China 2030 Plan" to achieve a 15% increase in the overall cancer survival rate over the past five years, co-sponsored by beijing Ai spectrum Cancer Patient Care Foundation, Roche Pharmaceuticals China, and the National Health And Wellness Commission People's Health Television Channel Live release of "China's lymphoma patients throughout the management of quality control standards", aimed at improving public awareness of lymphoma diseases, promote the standardization of lymphoma diagnosis and treatment in China, to meet the unfinished needs of lymphoma patients, the future will also vigorously promote clinical "medical, care, patient" integrated full management mode of diagnosis and treatment, improve the quality of life of lymphoma patients, so that more lymphoma patients to the road to cure.
professor Ma Jun network network to participate in the "China lymphoma patients throughout the management of quality control standards" release (left): Professor Zhu Jun, (middle) Professor Shi Anli, (right) Yan Xia chief nurse China's lymphoma status quo: misdiagnosis rate is high, low cure rate of lymphoma is a common malignant tumor originating from the lymphatic hematosis system, but also one of the higher incidence of tumors in recent years.
2018, the number of people with lymphoma in China is about 260,000, according to global cancer data released in 2018.
, there are about 100,000 new lymphoma patients in China every year, and the incidence of the population is younger trend, the prevention and treatment situation is serious.
lymphoma is one of the most controlled and cured tumors in the world, and after standardized treatment and management, the survival period can be greatly extended.
example, diffuse large B-cell lymphoma has been defined by the World Health Organization as a tumor that can be cured even in late stages, with a clinical cure rate of up to 70% after standard treatment.
with the continuous updating of treatment plans, the further coverage of health insurance policy, china's lymphoma patients treatment access to greatly improved.
But according to 2018 statistics in The Lancet, an authoritative medical journal, the five-year survival rate for patients with lymphoma in China was only 38.4%, while in the United States and Japan it was 68.1% and 57.3%, respectively.
The 2019 China Lymphoma Patient Survival Report White Paper shows that 43% of patients have experienced misdiagnosis and 51% have been diagnosed through multiple hospitals;
Professor Ma Jun, Director of Harbin Institute of Hematological Oncology, said: "Research shows that only 22.1% of patients with diffuse large B-cell lymphoma are treated with standardized 8 or more courses of treatment, indicating that the current situation of lymphoma patients in China to receive standardized treatment is not ideal, treatment compliance is also relatively poor, seriously affecting the quality of life of patients."
refore, lymphoma as a synthesis that takes into account the characteristics of chronic disease and tumor, lymphoma patients from the doctor to guide, promote standardized diagnosis and treatment, to the rehabilitation period follow-up of the whole process of management is particularly important.
" lymphoma patients are not necessary: full management, standardized diagnosis and treatment for China's lymphoma patients face high misdiagnosis rate, treatment and follow-up compliance with the actual problems, need to learn from foreign cancer patients' individual full management model, carry out a comprehensive, large-scale "lymphoma patients full management" work, aimed at promoting the standardized diagnosis and treatment of lymphoma patients, strengthen the full management of lymphoma patients, improve the quality of survival and survival rate of patients.
The "China Lymphoma Patients Full Management Quality Control Standard" clearly defines the concept of "full management of lymphoma patients", including patient consultation guidance, standardized diagnosis and treatment promotion and rehabilitation follow-up three parts, through multidisciplinary diagnosis and treatment team to guide potential lymphoma patients to carry out relevant examinations to achieve early diagnosis;
improve the misdiagnosis and psychological burden of patients, improve the overall survival rate of patients.
, strengthening the standardized diagnosis and treatment of patients with lymphoma and full management is very important to improve the cure rate of lymphoma.
" lymphoma standardized diagnosis and treatment has always been the concept of clinical unchanged.
Professor Zhu Jun, Party Secretary and Director of Lymphoma Department of Peking University Cancer Hospital, said, "In the 1990s, the original lytoxides entered the clinic, and China has made significant improvements in the treatment of lymphoma, and the cure rate has increased significantly."
, more and more innovative treatment options have emerged, bringing new options and hope to the treatment of lymphoma patients.
need more attention to patient pain points, with case-by-case management model, to carry out extensive and comprehensive management of diagnosis and treatment.
for patients should also carry out the corresponding disease education and follow-up management, to ensure the compliance of patients with regular follow-up visits, to establish a patient-centered, medical, medical, patient consultation and treatment integration of the whole management model.
" whole management multi-party building: caring for patients, winning the treatment of lymphoma patients full management care consultant refers to as a "link" closely linked patients and treatment team, the whole process involved in patient treatment and rehabilitation of medical workers.
as the most contact with lymphoma patients throughout the management care consultant, has played a key role in disease management, can help improve patient treatment compliance and other issues.
The whole process management care consultant is mainly responsible for patient visit guidance, standardized diagnosis and rehabilitation follow-up, diagnosis and treatment management, and provide patients with information, emotional and psychological support services, to provide patients with comprehensive, full, continuous care and care.
The diagnosis to treatment to follow-up of lymphoma is a very long process, covering the diagnosis, care, psychology and other aspects of patients with lymphoma," said Yan Xia, chief nurse of hematology department at Peking University People's Hospital.
standardized specialist care is an indispensable part of the whole management of lymphoma, which can bring great benefits to patients.
The whole management care consultant is the core role in the standardization of nursing, the whole process management service for patients, to provide practical help to patients, and the whole management of lymphoma and the improvement of specialized nursing capacity is complementary, in improving the quality of patient care at the same time, but also make excellent care consultants become nursing experts.
" The release of the "China Lymphoma Patients Full Management Quality Control Standard" by the country's 19 deans, professors and a large number of health care workers to participate in the co-construction, as one of the sponsors of the Standard, Beijing Love Spectrum Cancer Patient Care Foundation Management Committee Chairman, China Anti-Cancer Association Rehabilitation Branch Chairman Shi An "This year is the fifth anniversary of the release of the 'Healthy China 2030' policy, and with the gradual progress of the National Health China Initiative 2030, tumors have been treated as chronic diseases throughout the life cycle, and many mid- to late-stage cancer treatments have gradually move closer to chronic disease management," Professor Leigh said.
with the continuous improvement of the diagnosis and treatment model, the whole management model has become more and more familiar with and accepted by the public and patients.
believes that more lymphoma patients will benefit from longer-term survival in the future as the model is rolled out in hospitals across the country.
"Attached: Participating in the "China Lymphoma Patient Management Quality Control Standard" published by the list of experts <!--/ewebeditor:page->